These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Why big pharma needs little bio

On 26 January, in London, Science|Business organised a roundtable of executives in the biotech industry to discuss the state of the market. The consensus: investor appetite for biotech companies is on the rise.